UPB Upstream Bio, Inc.
Nasdaq · SEC CIK 2022626 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $104.8K 15 sales by 5 insiders
- Filings on record
- 48 since 2024-10-15, latest 2026-09-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Sutherland Everett Rand | CEO, Dir | — | $43.7K |
| Deykin Aaron | Chief Medical Off | — | $18.7K |
| GRAY MICHAEL | CFO, COO | — | $17.8K |
| Houghton Adam | Chief Business Off | — | $14.6K |
| Ambrose Allison | GC | — | $9,985 |
Transactions 27
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:05 | 2026-09-16 | UPB | GRAY MICHAEL | CFO, COO | S - Sale | $5.49 | -853 | 27.9K | -3% | -$4,683 | |
| 2026-09-17 16:05 | 2026-09-16 | UPB | Ambrose Allison | GC | S - Sale | $5.49 | -485 | 15.6K | -3% | -$2,663 | |
| 2026-09-17 16:05 | 2026-09-16 | UPB | Deykin Aaron | Chief Medical Off | S - Sale | $5.49 | -895 | 32.3K | -3% | -$4,914 | |
| 2026-09-17 16:05 | 2026-09-16 | UPB | Sutherland Everett Rand | CEO, Dir | S - Sale | $5.49 | -2,095 | 68.7K | -3% | -$11.5K | |
| 2026-09-17 16:05 | 2026-09-16 | UPB | Houghton Adam | Chief Business Off | S - Sale | $5.49 | -700 | 22.9K | -3% | -$3,843 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | GRAY MICHAEL | CFO, COO | S - Sale | $6.10 | -853 | 28.8K | -3% | -$5,203 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Sutherland Everett Rand | CEO, Dir | S - Sale | $6.10 | -2,095 | 70.8K | -3% | -$12.8K | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Houghton Adam | Chief Business Off | S - Sale | $6.10 | -700 | 23.6K | -3% | -$4,270 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Deykin Aaron | Chief Medical Off | S - Sale | $6.10 | -895 | 33.2K | -3% | -$5,460 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Ambrose Allison | GC | S - Sale | $6.10 | -477 | 16.0K | -3% | -$2,910 | |
| 2026-03-17 | 2026-03-16 | UPB | Ambrose Allison | GC | S - Sale | $9.29 | -475 | 16.5K | -3% | -$4,413 | |
| 2026-03-17 | 2026-03-16 | UPB | Houghton Adam | Chief Business Off | S - Sale | $9.29 | -699 | 24.3K | -3% | -$6,494 | |
| 2026-03-17 | 2026-03-16 | UPB | GRAY MICHAEL | CFO, COO | S - Sale | $9.29 | -852 | 29.6K | -3% | -$7,915 | |
| 2026-03-17 | 2026-03-16 | UPB | Deykin Aaron | Chief Medical Off | S - Sale | $9.29 | -894 | 32.7K | -3% | -$8,305 | |
| 2026-03-17 | 2026-03-16 | UPB | Sutherland Everett Rand | CEO, Dir | S - Sale | $9.29 | -2,093 | 72.9K | -3% | -$19.4K | |
| D | 2026-01-06 | 2026-01-02 | UPB | Deykin Aaron | Chief Medical Off | A - Grant | $0.00 | +32.0K | 33.6K | +2,024% | $0 |
| D | 2026-01-06 | 2026-01-02 | UPB | GRAY MICHAEL | CFO, COO | A - Grant | $0.00 | +30.5K | 30.5K | New | $0 |
| D | 2026-01-06 | 2026-01-02 | UPB | Houghton Adam | Chief Business Off | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2026-01-06 | 2026-01-02 | UPB | Ambrose Allison | GC | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
| D | 2026-01-06 | 2026-01-02 | UPB | Sutherland Everett Rand | CEO, Dir | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| DMI | 2024-10-17 | 2024-10-15 | UPB | ORBIMED ADVISORS LLC | Dir, 10% | C - Cnv Deriv | — | +3.61M | 973.7K | New | — |
| DMI | 2024-10-17 | 2024-10-15 | UPB | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $17.00 | +825.0K | 4.55M | +22% | +$14.03M |
| DT | 2024-10-17 | 2024-10-15 | UPB | Access Industries Holdings LLC | 10% | P - Purchase | $17.00 | +1.18M | 1.18M | New | +$19.98M |
| DMT | 2024-10-17 | 2024-10-15 | UPB | Access Industries Holdings LLC | 10% | C - Cnv Deriv | — | +4.32M | 5.49M | +368% | — |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Chimovits Erez | Dir, 10% | C - Cnv Deriv | — | +3.61M | 3.89M | +1,266% | — |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Chimovits Erez | Dir, 10% | P - Purchase | $17.00 | +825.0K | 4.55M | +22% | +$14.03M |
| D | 2024-10-15 | 2024-10-15 | UPB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | C - Cnv Deriv | — | +894.7K | 894.7K | New | — |